Blog
All Posts
4 posts
Research
New KRAS-Targeted Drug Shows Real Promise for Pancreatic Cancer Patients
A new drug called daraxonrasib targets KRAS mutations found in over 90% of pancreatic cancers, showing a 47% response rate and 83% six-month overall survival in an early clinical trial.
3 min read
Patient StoriesWelcome to My Chemo Diary
A calm space for people receiving chemotherapy and for the caregivers walking beside them.
2 min read
NutritionA Practical Nutrition Guide During Chemotherapy
Good nutrition can help patients maintain strength, tolerate side effects, and recover during chemotherapy. Here are practical food and hydration strategies.
4 min read
Emotional HealthProtecting Your Emotional Health During Chemotherapy
Cancer diagnosis and chemotherapy affect the mind as well as the body. Learn gentle ways to handle anxiety, sadness, fear, and support needs.
4 min read